As the Covid-19 situation develops we want to keep our clients and community updated on the impact on our industry. Here are the latest updates from APLUSA as of March 27, 2020.

Replies from HCP respondents in our network

Following the message we sent to healthcare professionals in our network of study respondents, we received encouraging replies from specialists including ophthalmologists, dermatologists, hematologists, rheumatologists, surgeons, paediatricians, gastros, cardiologists, neurologists, oncologists, endos and more. Replied included the following:

“Thank you all, you can count on me.” – Emergency Specialist

“Thank you, I remain at your disposal.” – Oncologist

“With the situation, I cannot guarantee the same reactivity, depending on when I will be solicited.” – Head of Ward Rehabilitation Medicine

“I was very motivated by your message; I am totally available in this period since I had to stop all activities.” – Dentist

APLUSA monitoring of data collection feasibility

• Data-collection feasibility is currently OK in the US and the Middle East
• Data-collection is restarting in China and Korea
• We have seen a slow down in France, UK, EU, and LATAM